Capital Research Global Investors Takeda Pharmaceutical CO LTD Transaction History
Capital Research Global Investors
- $510 Billion
- Q3 2025
A detailed history of Capital Research Global Investors transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Capital Research Global Investors holds 13,404,129 shares of TAK stock, worth $192 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,404,129
Previous 13,295,573
0.82%
Holding current value
$192 Million
Previous $206 Million
4.53%
% of portfolio
0.04%
Previous 0.04%
Shares
19 transactions
Others Institutions Holding TAK
# of Institutions
386Shares Held
80.7MCall Options Held
1.7MPut Options Held
276K-
Morgan Stanley New York, NY7.69MShares$110 Million0.01% of portfolio
-
Ubs Group Ag5.89MShares$84.2 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.95MShares$70.8 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.93MShares$56.2 Million0.48% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.86MShares$55.2 Million0.08% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...